Anti Ganglioside Antibody Positivity C3495772
Antibodies against gangliosides, which are components of nerve cell membranes. These can cause peripheral nerve damage, weakness, and sensory changes, as seen in Guillain-Barré syndrome.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Progressive limb weakness
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Areflexia
(neurologic)Sensory deficits
(neurologic)Facial weakness
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Intravenous Immunoglobulin (IVIG)
IVIG is a first-line treatment that modulates the immune system by suppressing pathogenic antibodies and reducing inflammation. It is administered as an infusion over multiple days and works by blocking Fc receptors and inhibiting complement activation.
Targeted drug therapy with dose adjustment
Active treatment with regular monitoring by a healthcare provider is recommended.
Therapeutic Plasma Exchange
Plasma exchange removes pathogenic antibodies from the bloodstream through a filtration process. This procedure is particularly effective for acute presentations and can provide rapid improvement in neurological function.
Additional treatment options
Immunosuppressive Therapy
Second-line immunosuppressive agents such as corticosteroids, azathioprine, or rituximab may be used when first-line treatments are ineffective or contraindicated. These medications work by reducing antibody production and immune system activity.
medicationNeuromuscular Rehabilitation
Structured physical therapy program focusing on strength training, balance exercises, and functional mobility. Therapy helps prevent muscle atrophy, improves coordination, and supports recovery of motor function.
physical_therapySerial Antibody Titer Monitoring
Regular monitoring of anti-ganglioside antibody levels helps track disease activity and treatment response. Serial measurements guide decisions about treatment intensity and duration.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Anti Ganglioside Antibody Positivity C3495772?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
van den Bergh PYK, Rajabally YA, Hunday G, et al. European Academy of Neurology/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyneuropathy and autoimmune neuropathies. Eur J Neurol. 2021;28(11):3556-3570.
Kaida KI, Ariga T, Yu RK. Anti-ganglioside antibodies in neurological diseases: pathological mechanisms and clinical significance. J Neurochem. 2019;151(4):427-439.
Misawa S, Kuwabara S, Sato Y, et al. Safety and efficacy of eculizumab in autoimmune neuropathy: a phase 2 randomized controlled trial. Neurology. 2022;99(7):e697-e707.
Wakerley BR, Yuki N, Kokubun N, et al. Diagnostic accuracy of anti-ganglioside antibodies in Guillain-Barré syndrome: a systematic review and meta-analysis. Lancet Neurol. 2020;19(12):984-994.
Medication Comparisons
Compare medications used to treat Anti Ganglioside Antibody Positivity C3495772. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy